4/5 November 2020
The Pharmaceutical Inspection Co-operation Scheme PIC/S has published a PIC/S Guide to Good Distribution Practice for Medicinal Products (PE 011-1). This Guide is based on the EU GDP-Guidelines (2013/C 343/01) and quotes the EU Guide almost completely.
However, EU specific references have been deleted and the term "must" is often replaced by the term "should". A dedicated Responsible Person is not introduced by the PIC/S document. It talks about "designated responsible person(s)" or "designated person(s)". Chapter 2.2 "Responsible person" of the EU GDP Guide is not quoted in the PIC/S document.
Also import activities are covered by the PIC/S Guide. EU GDP Chapter 5.9 "Export to third countries" has been amended and also covers import activities. Chapter 10 "Specific provisions for brokers" has been deleted completely.
The structure of the PIC/S document has been aligned with the structure of the EU GMP Guidelines, including 9 chapters:
As with the EU Guidelines, Risk Assessments will become a key tool for implementation of the new requirements.
PE 011-1 is now an official PIC/S guidance document. This does not mean that it is automatically in force in all PIC/S member states. It is a non-binding guidance and PIC/S Participating Authorities need to decide whether it should become a legally-binding standard and then implement it accordingly. Implementation should take into consideration national legislation. In some PIC/S countries for example, importation may fall under GMP and a manufacturer's license may be required.
Currently, PIC/S has 46 Participating Authorities, including most EU Member States, Switzerland, Japan and the USA.